医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

IMS Institute for Healthcare Informatics Launches Branch in India

2013年03月08日 AM01:10
このエントリーをはてなブックマークに追加


 

DELHI, India

The IMS Institute for Healthcare Informatics today announced a new initiative to develop local partnerships with leading universities, research institutions, development agencies and the government to reinforce the value of information and analytics in decision making across a range of healthcare issues in India. The India Branch of the IMS Institute for Healthcare Informatics, with the support of IMS Health India, will leverage relationships in the public and private sectors to deliver objective, relevant insights and research to advance the country’s health agenda.

“The transformation of healthcare systems to better serve the needs of patients worldwide can be energized through a tighter linkage between information and decisions,” said Murray Aitken, who heads the IMS Institute for Healthcare Informatics. “There is a tremendous opportunity to ensure that the best available information – including IMS’s unparalleled global information and analytical assets – is applied as critical reforms are undertaken across India. Through the India Branch, we are establishing a platform for collaboration among academia and the country’s private and public sector stakeholders to help drive the creation of critical research networks, greater information sharing and the innovative mapping of disease burdens.”

In India, the IMS Institute’s activities will focus on three areas:

  • Mobilizing and advancing health services research: The Institute will bring together leading policy advisors, educators, researchers and medical care providers to initiate research activities and apply evidence-based approaches to address key healthcare issues.
  • Capacity-building and professional training: Programs that harness the unique knowledge and expertise of IMS researchers and specialists will be developed for key decision makers, including healthcare executives, hospital administrators and policy makers.
  • Analytics-based performance improvement: The Institute will support efforts by health institutions to use performance-based analytics and Business Intelligence tools to drive informed decision making and improved healthcare costs and outcomes.

“This is an exciting initiative, and my colleagues and I are looking forward to advancing this distinctive agenda in collaboration with India’s healthcare stakeholders,” said Dr. Gopa Kumar Raghavan, who heads the India Branch of the IMS Institute. “IMS Health’s information, insights and global perspective will provide a unique foundation for critical dialogue to accelerate healthcare development and encourage effective policy decision making.”

About the IMS Institute for Healthcare Informatics

The IMS Institute for Healthcare Informatics provides key policy setters and decision makers in the global health sector with unique and transformational insights into healthcare dynamics derived from granular analysis of information. It is a research-driven entity with a worldwide reach that collaborates with external healthcare experts from across academia and the public and private sectors to objectively apply IMS’s proprietary global information and analytical assets. More information about the IMS Institute can be found at: http://www.theimsinstitute.org.

About IMS Health

IMS Health is a leading worldwide provider of information, technology, and services dedicated to making healthcare perform better. With a global technology infrastructure and unique combination of real-world evidence, advanced analytics and proprietary software platforms, IMS Health connects knowledge across all aspects of healthcare to help clients improve patient outcomes and operate more efficiently. The company’s expert resources draw on data from nearly 100,000 suppliers, and on insights from 39 billion healthcare transactions processed annually, to serve more than 5,000 healthcare clients globally. Customers include pharmaceutical, medical device and consumer health manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community. Additional information is available at www.imshealth.com.

CONTACT

IMS Health
Maria Martinez, + 65 6412-7369
mjmgarcia@sg.imshealth.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Walmart, JD.com, IBM and Tsinghua University Launch a Blockchain Food Safety Alliance in China
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-402の第I相中間データを発表
  • Vedanta Biosciences Granted Four New U.S. Patents Expanding Coverage for Compositions and Methods of Use for Therapeutics Based on Microbiome-Derived Bacterial Consortia
  • Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer
  • 武田和Seattle Genetics呈报3期ECHELON-1临床试验的阳性数据,该试验评估ADCETRIS® (brentuximab vedotin)用于晚期霍奇金淋巴瘤的一线治疗